Chemotherapy in Treating Patients With Recurrent Malignant Glioma
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of topotecan plus carmustine in patients
with recurrent primary malignant glioma.